What is Neureval?
Neureval operates a sophisticated platform dedicated to the analysis of EEG brain wave patterns. Its core offerings are designed to facilitate the exploration and interpretation of neurological data across a spectrum of applications. The company primarily serves researchers, healthcare professionals, and technology developers who are at the forefront of brain-computer interface innovations. By enhancing the understanding of brain activity, Neureval aims to contribute to advancements in neuroscience and improve user experiences in related technological fields.
How much funding has Neureval raised?
Neureval has raised a total of $17K across 1 funding round:
Debt
$17K
Debt (2021): $17K with participation from PPP
Key Investors in Neureval
PPP
Public-Private Partnership
What's next for Neureval?
With the recent capital injection, Neureval is poised for accelerated expansion and product development. The Series A/B growth stage funding suggests a strategic focus on scaling operations, enhancing its platform's analytical capabilities, and potentially broadening its market penetration. Future endeavors are likely to involve deeper integration into healthcare systems and further exploration of brain-computer interface applications, leveraging its proprietary EEG analysis technology to drive innovation and establish a stronger market presence.
See full Neureval company page
